The present disclosure provides oral liquid compositions including carvedilol with enhanced solubility and stability. Also provided herein are methods of using oral liquid compositions for the treatment of hypertension, treatment of heart failure, and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
